Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0003 Transporter Info | ||||
| Gene Name | ABCB1 | ||||
| Transporter Name | P-glycoprotein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Azelastine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 2267 | ||||
| Docking Score | -9.29 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C22H24ClN3O | ||||
| Molecular Weight | 381.9 | ||||
| Canonical SMILES |
CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
|
||||
| InChI |
InChI=1S/C22H24ClN3O/c1-25-13-4-5-18(12-14-25)26-22(27)20-7-3-2-6-19(20)21(24-26)15-16-8-10-17(23)11-9-16/h2-3,6-11,18H,4-5,12-15H2,1H3
|
||||
| InChIKey | MBUVEWMHONZEQD-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.4 | Rotatable Bond Count | 3 | |
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | ||
| Xenobiotic Name | Chlorprothixene Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 667467 | ||||
| Docking Score | -9.283 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C18H18ClNS | ||||
| Molecular Weight | 315.9 | ||||
| Canonical SMILES |
CN(C)CC/C=C\\1/C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
|
||||
| InChI |
InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-
|
||||
| InChIKey | WSPOMRSOLSGNFJ-AUWJEWJLSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5.2 | Rotatable Bond Count | 3 | |
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | ||
| Xenobiotic Name | Amprenavir Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 65016 | ||||
| Docking Score | -9.264 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C25H35N3O6S | ||||
| Molecular Weight | 505.6 | ||||
| Canonical SMILES |
CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N
|
||||
| InChI |
InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1
|
||||
| InChIKey | YMARZQAQMVYCKC-OEMFJLHTSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.9 | Rotatable Bond Count | 12 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 8 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.